Accelerated cGMP production of near-native HIV-1 Env trimers following electroporation transfection and immunogenicity analysis.

Saved in:
Bibliographic Details
Title: Accelerated cGMP production of near-native HIV-1 Env trimers following electroporation transfection and immunogenicity analysis.
Authors: Bale S; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA., Gustchina E; ABL Inc., Rockville, MD, USA., Guenaga J; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; International AIDS Vaccine Initiative, Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA., Ayala V; ABL Inc., Rockville, MD, USA., Lee WH; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, USA., Ozorowski G; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, USA., Whitney S; ABL Inc., Rockville, MD, USA., Wilson R; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA., Baboo S; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, USA., Diedrich JK; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, USA., Doyle ED; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA., Hudacik L; ABL Inc., Rockville, MD, USA., Ben-Akiva E; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA., Rodrigues KA; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA., Irvine DJ; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA.; Howard Hughes Medical Institute, 4000 Jones Bridge Rd., Chevy Chase, MD, USA., Yates JR 3rd; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, USA., Paulson JC; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, USA.; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA., Ward AB; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, USA.; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA., Fouts T; ABL Inc., Rockville, MD, USA. timothy.fouts@ablinc.com., Wyatt RT; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA. wyatt@scripps.edu.; International AIDS Vaccine Initiative, Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA. wyatt@scripps.edu.; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA. wyatt@scripps.edu.
Source: NPJ vaccines [NPJ Vaccines] 2025 Aug 20; Vol. 10 (1), pp. 198. Date of Electronic Publication: 2025 Aug 20.
Publication Type: Journal Article
Journal Info: Publisher: Springer Nature in partnership with the Sealy Center for Vaccine Development Country of Publication: England NLM ID: 101699863 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-0105 (Electronic) Linking ISSN: 20590105 NLM ISO Abbreviation: NPJ Vaccines Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40835829
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Accelerated cGMP production of near-native HIV-1 Env trimers following electroporation transfection and immunogenicity analysis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Bale+S%22">Bale S</searchLink>; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Gustchina+E%22">Gustchina E</searchLink>; ABL Inc., Rockville, MD, USA.<br /><searchLink fieldCode="AU" term="%22Guenaga+J%22">Guenaga J</searchLink>; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; International AIDS Vaccine Initiative, Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Ayala+V%22">Ayala V</searchLink>; ABL Inc., Rockville, MD, USA.<br /><searchLink fieldCode="AU" term="%22Lee+WH%22">Lee WH</searchLink>; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, USA.<br /><searchLink fieldCode="AU" term="%22Ozorowski+G%22">Ozorowski G</searchLink>; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, USA.<br /><searchLink fieldCode="AU" term="%22Whitney+S%22">Whitney S</searchLink>; ABL Inc., Rockville, MD, USA.<br /><searchLink fieldCode="AU" term="%22Wilson+R%22">Wilson R</searchLink>; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Baboo+S%22">Baboo S</searchLink>; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Diedrich+JK%22">Diedrich JK</searchLink>; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Doyle+ED%22">Doyle ED</searchLink>; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Hudacik+L%22">Hudacik L</searchLink>; ABL Inc., Rockville, MD, USA.<br /><searchLink fieldCode="AU" term="%22Ben-Akiva+E%22">Ben-Akiva E</searchLink>; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Rodrigues+KA%22">Rodrigues KA</searchLink>; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Irvine+DJ%22">Irvine DJ</searchLink>; Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA.; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA.; Howard Hughes Medical Institute, 4000 Jones Bridge Rd., Chevy Chase, MD, USA.<br /><searchLink fieldCode="AU" term="%22Yates+JR+3rd%22">Yates JR 3rd</searchLink>; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Paulson+JC%22">Paulson JC</searchLink>; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA.; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, USA.; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Ward+AB%22">Ward AB</searchLink>; Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, USA.; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA.<br /><searchLink fieldCode="AU" term="%22Fouts+T%22">Fouts T</searchLink>; ABL Inc., Rockville, MD, USA. timothy.fouts@ablinc.com.<br /><searchLink fieldCode="AU" term="%22Wyatt+RT%22">Wyatt RT</searchLink>; Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA, USA. wyatt@scripps.edu.; International AIDS Vaccine Initiative, Neutralizing Antibody Center, The Scripps Research Institute, La Jolla, CA, USA. wyatt@scripps.edu.; Consortium for HIV/AIDS Vaccine Development, The Scripps Research Institute, La Jolla, CA, USA. wyatt@scripps.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101699863%22">NPJ vaccines</searchLink> [NPJ Vaccines] 2025 Aug 20; Vol. 10 (1), pp. 198. <i>Date of Electronic Publication: </i>2025 Aug 20.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Nature+in+partnership+with+the+Sealy+Center+for+Vaccine+Development%22">Springer Nature in partnership with the Sealy Center for Vaccine Development </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101699863 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2059-0105 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220590105%22">20590105 </searchLink><i>NLM ISO Abbreviation: </i>NPJ Vaccines <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40835829
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41541-025-01218-6
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 198
    Titles:
      – TitleFull: Accelerated cGMP production of near-native HIV-1 Env trimers following electroporation transfection and immunogenicity analysis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Bale S
      – PersonEntity:
          Name:
            NameFull: Gustchina E
      – PersonEntity:
          Name:
            NameFull: Guenaga J
      – PersonEntity:
          Name:
            NameFull: Ayala V
      – PersonEntity:
          Name:
            NameFull: Lee WH
      – PersonEntity:
          Name:
            NameFull: Ozorowski G
      – PersonEntity:
          Name:
            NameFull: Whitney S
      – PersonEntity:
          Name:
            NameFull: Wilson R
      – PersonEntity:
          Name:
            NameFull: Baboo S
      – PersonEntity:
          Name:
            NameFull: Diedrich JK
      – PersonEntity:
          Name:
            NameFull: Doyle ED
      – PersonEntity:
          Name:
            NameFull: Hudacik L
      – PersonEntity:
          Name:
            NameFull: Ben-Akiva E
      – PersonEntity:
          Name:
            NameFull: Rodrigues KA
      – PersonEntity:
          Name:
            NameFull: Irvine DJ
      – PersonEntity:
          Name:
            NameFull: Yates JR 3rd
      – PersonEntity:
          Name:
            NameFull: Paulson JC
      – PersonEntity:
          Name:
            NameFull: Ward AB
      – PersonEntity:
          Name:
            NameFull: Fouts T
      – PersonEntity:
          Name:
            NameFull: Wyatt RT
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 20
              M: 08
              Text: 2025 Aug 20
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2059-0105
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: NPJ vaccines
              Type: main
ResultId 1